Scientific corner

Adsorptive granulocyte and monocyte apheresis: A potentially relevant therapeutic option for COVID-19

Takuro Kanekura 1Koichi Kawahara 2 , Int J Infect Dis 2020 Oct;99:1-2. 

To our knowledge, GMA has a good safety profile; serious adverse effects are rarely reported. Its modes of action together with the findings of this case report support our notion that GMA is a relevant therapeutic option for patients with COVID-19 and warrants an immediate clinical trial to evaluate its full therapeutic efficacy in a large cohort of COVID-19 patients.

Contact UsFor more information

Contact Us